Укр Eng
Events

Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS

Join the representatives of Abbott, Acino Pharma, Baxter, Bayer, Bionorica, Delta Medical, Dr. Reddy's, Egis, EU Pharmacia, GlaxoSmithKline, Innotech International, Ipsen Pharma, Jadran, KRKA, MSD, MSH, Novo Nordisk, Polfa, Sanofi, Servier, Shire, Teva, UCB etc. to be aware of the main regulatory trends in the Ukrainian pharmaceutical market.

Experts
and participants

Legal Alliance Company invites уou to participate in the Summary Conference "Pharma Business: 2016 Conclusions – 2017 Anticipations" is an annual event for pharmaceutical industry representatives concerning the regulatory aspects of pharmaceutical business.

DATE: 02 FEBRUARY 2017 | DURATION: 08.30 - 15.00

VENUE: RAMADA ENCORE KIEV, Kyiv Ballroom (103, Stolychne Shose, Kyiv)

Join the representatives of Abbott, Acino Pharma, Baxter, Bayer, Bionorica, Delta Medical, Dr. Reddy's, Egis, EU Pharmacia, GlaxoSmithKline, Innotech International, Ipsen Pharma, Jadran, KRKA, MSD, MSH, Novo Nordisk, Polfa, Sanofi, Servier, Shire, Teva, UCB etc. to be aware of the main regulatory trends in the Ukrainian pharmaceutical market.


FINANCIAL CONDITIONS:

Registration fee


REGISTRATION FEE

UAH 4500

20% Discounts*

  • For Legal Alliance Customers and Partners.
  • For the third and the following participant from the same organization registering simultaneously.

UAH 3700 

*Discounts are not cumulative


LANGUAGE: Russian / Ukrainian. Simultaneous translation will not be provided.

For any assistance regarding registration and participation, please, address the Legal Alliance Company marketing department at the tel. No +380 (44) 425-40-50 or send an e-mail to duginova@l-a.com.ua.

WE WILL BE GLAD TO SEE YOU AND YOUR COLLEAGUES AMONG THE PARTICIPANTS!

OUR PARTNERS


































Legal Media Partner
Legal Media Partner


Speakers

Other conditions

Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS
Summary Conference PHARMA BUSINESS: 2016 CONCLUSIONS – 2017 ANTICIPATIONS

Get information about current events

By clicking the button, you consent to the processing of personal data